Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17491562 | 1.00 | SLC18A3 (0.55) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL17506075 | 1.00 | SLC18A3 (0.55) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL7536784 | 0.97 | SLC18A3 (0.59) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL7536782 | 0.97 | SLC18A3 (0.59) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL7536778 | 0.97 | SLC18A3 (0.59) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL17491563 | 0.88 | SLC18A3 (0.59) | SLC18A3 | |
| SCHEMBL18708687 | 0.88 | SLC18A3 (0.56) | SLC18A3KDM4ELMNAGLAGAA | |
| SCHEMBL7537160 | 0.85 | SLC18A3 (0.62) | SLC18A3 | |
| SCHEMBL7537155 | 0.85 | SLC18A3 (0.62) | SLC18A3 | |
| SCHEMBL7537087 | 0.82 | SLC18A3 (0.56) | SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9610369-B2 | Compound suitable for detection of vesicular acetylcholine transporter | HAMAMATSU PHOTONICS K.K. (JP) | 2017-04-04 | — | — | US | disclosed |
| US-20160051711-A1 | COMPOUND SUITABLE FOR DETECTION OF VESICULAR ACETYLCHOLINE TRANSPORTER | NARD INSTITUTE, LTD. (JP) | 2016-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160051711-A1 | COMPOUND SUITABLE FOR DETECTION OF VESICULAR ACETYLCHOLINE TRANSPORTER | SLC18A3, SLC18A2, CHAT | SLC18A3 1/4885KDM4E 3576/4885LMNA 4041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.